|
|
| Research article summary (published 7 Sep 2008): |
Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Learn Faster Today Improve your study skills
Author information
Author/s: Djupesland, Per Gisle (PG);
Journal and publication information
Publication Type: Comment; Letter
Journal: Neurology (Neurology), published in United States. (Language: eng)
Reference: 2008-Sep; vol 71 (issue 11) : pp 864; author reply 864
Dates: Created 2008/09/09; Completed 2008/10/03;
PMID: 18779519, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: Neurology. 2008 Feb 5;70(6):440-8. (PMID: 17942819)
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
15 Oct 2007 - Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
30 Mar 2008 - Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment.
29 Nov 2005 - Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
30 Oct 2005 - The diagnostic value of tau protein, beta-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages.
30 Jul 2005 - Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition.
29 Sep 2005 - Insulin and cognitive function in humans: experimental data and therapeutic considerations.
30 Oct 2005 - Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
25 Jun 2006 - Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.
12 Jul 2005 - Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease.
28 Feb 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.